Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8104)
All Articles published online
|
Publishing Process of This Article
|
Sep 21, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang YC, Kong WZ, Jin QM, Chen J, Dong L. Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis. World J Gastroenterol 2015; 21(35): 10104-10112 [PMID: 26401075 DOI: 10.3748/wjg.v21.i35.10104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i35/10104.htm |
| Number | Citing Articles |
| 1 |
Li Cao, Jian Zhou, Jinhua Wen. Transport of salvianolic acid B via the human organic anion transporter 1B1 in the liver. Phytotherapy Research 2019; 33(1): 197 doi: 10.1002/ptr.6216
|
| 2 |
Shanjun Tao, Renjie Duan, Tong Xu, Jiao Hong, Wenjie Gu, Aiqin Lin, Likai Lian, Haoyu Huang, Jiangtao Lu, Tiechen Li. Salvianolic acid B inhibits the progression of liver fibrosis in rats via modulation of the Hedgehog signaling pathway. Experimental and Therapeutic Medicine 2021; 23(2) doi: 10.3892/etm.2021.11039
|
| 3 |
Yutian Wang, Junzi Wu, Anhua Shi. Literature Review on the Use of Herbal Extracts in the Treatment of Non-
Alcoholic Fatty Liver Disease. Endocrine, Metabolic & Immune Disorders - Drug Targets 2022; 22(11): 1123 doi: 10.2174/1871530322666220408123746
|
| 4 |
Cho Hyun Hwang, Eungyeong Jang, Jang-Hoon Lee. Pharmacological Benefits and Underlying Mechanisms of Salvia miltiorrhiza against Molecular Pathology of Various Liver Diseases: A Review. The American Journal of Chinese Medicine 2023; 51(07): 1675 doi: 10.1142/S0192415X23500763
|
| 5 |
Yingchun Wang, Juan Chen, Weizong Kong, Ruiping Zhu, Kai Liang, Quanxiang Kan, Yanhong Lou, Xiangyu Liu. Regulation of SIRT3/FOXO1 Signaling Pathway in Rats with Non-alcoholic Steatohepatitis by Salvianolic Acid B. Archives of Medical Research 2017; 48(6): 506 doi: 10.1016/j.arcmed.2017.11.016
|
| 6 |
Dandan Zhao, Jiacheng Zuo, Na Yu, Xin Fang, Fangfang Mo, Rui Wu, Tian Tian, Rufeng Ma, Yushan Gao, Dongwei Zhang, Guangjian Jiang, Sihua Gao. Salvianolic acid B improves glucolipid metabolism by regulating adipogenic transcription factors in mice with diet-induced obesity. Journal of Traditional Chinese Medical Sciences 2017; 4(3): 280 doi: 10.1016/j.jtcms.2017.07.003
|
| 7 |
Tingting Shi, Liping Yu, Rangxiao Zhuang, Jianjun Xi, Ruoyu He, Yidan Shao, Jinsong Huang, Shourong Liu, Xingxin Yang, Alessandro Granito. Regulation of Mitochondrial Function by Natural Products for the Treatment of Metabolic Associated Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2021; 2021: 1 doi: 10.1155/2021/5527315
|
| 8 |
Yu Yang, Yu Zhao, Wenzhen Li, Yuyao Wu, Xin Wang, Yijie Wang, Tingmei Liu, Tinghong Ye, Yongmei Xie, Zhiqiang Cheng, Jun He, Peng Bai, Yiwen Zhang, Liang Ouyang. Emerging targets and potential therapeutic agents in non-alcoholic fatty liver disease treatment. European Journal of Medicinal Chemistry 2020; 197: 112311 doi: 10.1016/j.ejmech.2020.112311
|
| 9 |
Yuqiao Liu, Yue Fan, Jibin Liu, Xiyang Liu, Xiuyan Li, Jingqing Hu. Application and mechanism of Chinese herb medicine in the treatment of non-alcoholic fatty liver disease. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1499602
|
| 10 |
Ruibing Li, Sam Toan, Hao Zhou. Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease. Aging 2020; 12(7): 6467 doi: 10.18632/aging.102972
|
| 11 |
Xiao Yu, Haiyan Zhang, Jielu Pan, Lu Zou, Ling Tang, Hongyu Miao, Peiyong Zheng, Lianjun Xing. Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis. Pharmaceutical Biology 2021; 59(1): 1357 doi: 10.1080/13880209.2021.1979594
|
| 12 |
Hong Yao, Yu-Jie Qiao, Ya-Li Zhao, Xu-Feng Tao, Li-Na Xu, Lian-Hong Yin, Yan Qi, Jin-Yong Peng. Herbal medicines and nonalcoholic fatty liver disease. World Journal of Gastroenterology 2016; 22(30): 6890-6905 doi: 10.3748/wjg.v22.i30.6890
|
| 13 |
Xiao-Feng Yan, Pei Zhao, Dong-Yan Ma, Yi-Lu Jiang, Jiao-Jiao Luo, Liu Liu, Xiao-Ling Wang. Salvianolic acid B protects hepatocytes from H<sub>2</sub>O<sub>2</sub> injury by stabilizing the lysosomal membrane. World Journal of Gastroenterology 2017; 23(29): 5333-5344 doi: 10.3748/wjg.v23.i29.5333
|
| 14 |
Zhun Xiao, Wei Liu, Yong-ping Mu, Hua Zhang, Xiao-ning Wang, Chang-qing Zhao, Jia-mei Chen, Ping Liu. Pharmacological Effects of Salvianolic Acid B Against Oxidative Damage. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.572373
|
| 15 |
Honglin Zhou, Cheng Ma, Cheng Wang, Lihong Gong, Yafang Zhang, Yunxia Li. Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease. European Journal of Pharmacology 2021; 898: 173976 doi: 10.1016/j.ejphar.2021.173976
|
| 16 |
Bohan Lv, Tian An, Tingye Wang, Xueli Bao, Juan Lian, Yanxiang Wu, Yuanyuan Hu, Jiajian Zhu, Chunyan Zheng, Xuehong Hu, Sihua Gao, Guangjian Jiang. Effects of salvianolic acid B on glycometabolism and lipid metabolism in rodents: Meta-analysis. Traditional Medicine and Modern Medicine 2020; 3(03): 175 doi: 10.1142/S2575900020300040
|
| 17 |
CONSUMPTION OF HYPERLIPIDEMIC DIET AND WATER INTAKE IN ALBINO RATS TREATED WITH ECLIPTA ALBA – ORIGINAL RESEARCH PAPER. Asian Journal of Pharmaceutical and Clinical Research 2023; : 147 doi: 10.22159/ajpcr.2023v16i9.47989
|
| 18 |
Chufeng Qin, Lichuan Luo, Yusheng Cui, Li Jiang, Beilei Li, Yijie Lou, Zhuofan Weng, Jingwen Lou, Chenxin Liu, Cuiting Weng, Zhaojun Wang, Yunxi Ji. Anti-Autophagy Mechanism of Zhi Gan Prescription Based on Network Pharmacology in Nonalcoholic Steatohepatitis Rats. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.708479
|
| 19 |
Merilin Al Sharif, Petko Alov, Vessela Vitcheva, Antonia Diukendjieva, Mattia Mori, Bruno Botta, Ivanka Tsakovska, Ilza Pajeva. Natural modulators of nonalcoholic fatty liver disease: Mode of action analysis and in silico ADME-Tox prediction. Toxicology and Applied Pharmacology 2017; 337: 45 doi: 10.1016/j.taap.2017.10.013
|
| 20 |
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li, Zhidong Liu. Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 2019; 117: 109128 doi: 10.1016/j.biopha.2019.109128
|
| 21 |
Xianmin Dai, Jiayi Feng, Yi Chen, Si Huang, Xiaofei Shi, Xia Liu, Yang Sun. Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives. Chinese Medicine 2021; 16(1) doi: 10.1186/s13020-021-00469-4
|
| 22 |
Jian-Kang Mu, Yan-Qin Li, Ting-Ting Shi, Li-Ping Yu, Ya-Qin Yang, Wen Gu, Jing-Ping Li, Jie Yu, Xing-Xin Yang. Remedying the Mitochondria to Cure Human Diseases by Natural Products. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/5232614
|